Pneumococcal meningitis in children: Epidemiology, serotypes, and outcomes from 1997-2010 in Utah

Pediatrics

Volumn 132, Issue 3, 2013, Pages 421-428

  Stockmann, Chris ^a   Ampofo, Krow ^a   Byington, Carrie L ^a   Filloux, Francis ^b   Hersh, Adam L ^a   Blaschke, Anne J ^a   Cowan, Priscilla ^a   Korgenski, Kent ^c   Mason, Edward O ^d   Pavia, Andrew T ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial meningitis; Children; Neurologic sequelae; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; ATAXIA; BEHAVIOR DISORDER; CEREBRAL BLINDNESS; CHILD; COHORT ANALYSIS; CRANIAL NERVE PARALYSIS; DEVELOPMENTAL DISORDER; FEMALE; HEMIPARESIS; HUMAN; HYDROCEPHALUS; HYPERACTIVITY; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MICROCEPHALY; MORTALITY; NEUROLOGICAL COMPLICATION; PERCEPTION DEAFNESS; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUADRIPLEGIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SEROTYPE; UNITED STATES;

EID: 84884556901     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0621     Document Type: Article

References (32)

1. Schlech WF III, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985;253(12):1749-1754
2. Haddy RI, Perry K, Chacko CE, et al. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2005;24(4):320-323
3. Schuchat A, Robinson K, Wenger JD, et al; Active Surveillance Team. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337(14):970-976
4. Chávez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(3):795-810, vii
5. Thigpen MC, Whitney CG, Messonnier NE, et al; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016-2025
6. Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746
7. Recommended immunization schedules for persons aged 0 through 18 years-United States, 2012 [published correction appears in MMWR Morb Mortal Wkly Rep. 2012;61(8):147]. MMWR Morb Mortal Wkly Rep. 2012;61(5):1-4
8. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis. 2008;46(11):1664-1672
9. Ampofo K, Pavia AT, Stockmann CR, et al. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J. 2011;30(12):1100-1103
10. Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, et al. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance Pediatr Infect Dis J. 2012;31(3):228-234
11. Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis. 1995;21(6):1390-1397
12. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med. 2009;7:47
13. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244-256
14. Shutt CK, Samore M, Carroll KC. Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates. J Clin Microbiol. 2004;42(3):1274-1276
15. Herson VC, Todd JK. Prediction of morbidity in Hemophilus influenzae meningitis. Pediatrics. 1977;59(1):35-39
16. Indicator-Based Information System for Public Health (IBIS-PH). Available at: http://ibis.health.utah.gov/query/result/pop/Pop-Main/Count.html. Accessed October 26, 2012
17. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106(2 pt 1):362-366
18. Pilishvili T, Lexau C, Farley MM, et al; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32-41
19. Bingen E, Levy C, Varon E, et al; Bacterial Meningitis Study Group. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis. 2008;27(3):191-199
20. Glanz JM, Newcomer SR, Narwaney KJ, et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274-281
21. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368(9546):1495-1502
22. Glanz JM, McClure DL, O'Leary ST, et al. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011;29(5):994-999
23. Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med. 2005;159(5):470-476
24. Gil Prieto R, San Román Montero J, Gómez Alejandre C, Alvaro Meca LA, Rivero A, Gil de Miguel A. Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998-2006). Vaccine. 2009;27(20):2669-2673
25. King BA, Richmond P. Pneumococcal meningitis in Western Australian children: epidemiology, microbiology and outcome. J Paediatr Child Health. 2004;40(11):611-615
26. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102(5):1087-1097
27. Jansen AG, Rodenburg GD, van der Ende A, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009;49(2):e23-e29
28. Rückinger S, von Kries R, Siedler A, van der Linden M. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J. 2009;28(2):118-122
29. Bohr V, Paulson OB, Rasmussen N. Pneumococcal meningitis. Late neurologic sequelae and features of prognostic impact. Arch Neurol. 1984;41(10):1045-1049
30. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126(pt 5):1015-1025
31. Chandran A, Herbert H, Misurski D, Santosham M. Long-term sequelae of childhood bacterial meningitis: an underappreciated problem. Pediatr Infect Dis J. 2011;30(1):3-6
32. Østergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis. 2005;5:93